Cite
HARVARD Citation
Takakuwa, T. et al. (2021). Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma. Hematological oncology. 39 (3), pp. 349-357. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takakuwa, T. et al. (2021). Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma. Hematological oncology. 39 (3), pp. 349-357. [Online].